Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – Versus Enoxaparin for Thromboprophylaxis After Total Knee Replacement
Alexander GG Turpie, MD
AAOS Clinical Guidelines: Prevention of Symptomatic Pulmonary Embolism in Patients undergoing THA and TKA
Paul F. Lachiewicz, MD
Are Hospitals Following Guidelines for VTE Prevention? The Veneous Thromoembolism Study to Assess the Rate of Thromboprophylaxis
Alpesh Amin MD, MBA, FACP